# Creathor Ventures

> Creathor Ventures is a VC fund backing Software and Health Care. See 93 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Bad Homburg, Germany
- Total investments: 93
- Last investment: Apr 2026
- Lead investor: 41%
- Fund size: $94M
- Last fund: Sep 2016
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/creathor-venture
- X (Twitter): http://twitter.com/creathorventure
- Website: http://www.creathor.com

Creathor Ventures is a VC fund in Bad Homburg focused on Software and Health Care. Creathor Ventures invests in technology-oriented companies that are driving the automation of industry and business as well as the personalization and digitalization of the healthcare sector. The regional focus is on Germany and Switzerland. From its offices in Bad Homburg and Zurich, the 15-strong team currently supports over 30 tech and lifescience companies. Over the past 30 years, the management team has financed over 200 companies as lead or co-lead investors. More than 20 companies have been listed on international stock exchanges. Creathor Ventures currently manages a fund volume of over 230 million euros.

## Contacts

5 contacts available for Creathor Ventures. Shizune tracks 7 team members at Creathor Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/creathor-venture-management?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $2M–$12M |
| Series B | $5.1M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 16 | 17% |
| Health Care | 13 | 14% |
| Biotechnology | 12 | 13% |
| Mobile | 10 | 11% |
| Internet | 9 | 10% |

95 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 28 | 30% |
| Funding Round | 19 | 20% |
| Series B | 18 | 19% |
| Seed | 15 | 16% |
| Series C | 4 | 4% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 37 | 40% |
| Switzerland | 7 | 8% |
| United States | 5 | 5% |
| France | 4 | 4% |
| Finland | 3 | 3% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Angela Will-Jamin | PR & Team Assistant | 0 | https://shizune.co/investors/profile/angela-will-jamin |
| Cedric Kohler | Managing Partner | 17 | https://shizune.co/investors/profile/cdric-khler |
| Gert Kohler | Founder and Chairman | 5 | https://shizune.co/investors/profile/dr-gert-khler |
| Karlheinz Schmelig | Managing Partner | 15 | https://shizune.co/investors/profile/karlheinz-schmelig |
| Lisa Fahrner | Finance Manager | 0 | https://shizune.co/investors/profile/lisa-fahrner |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tacalyx | Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms. | $12.9M | Seed | Apr 29, 2026 |  |
| HeyJobs | HeyJobs is a Talent Platform that helps employers find the right talents at a friction of the traditional cost per hire. It helps talents find jobs that enable them to live a fulfilling life. Through a combination of machine learning, automation and software, we have created >50'000 hires already. | $47M | Series B | Mar 24, 2022 |  |
| Ledgy | Ledgy is a developer of a valuation tracking platform designed to manage equity capital and employee participation.The company's platform streamlines the overview of vesting plans, phantom programs, and numbered shares. This gives entrepreneurs and shareholders insights into their capital table, funding rounds, or exit talks.Ledgy wasestablished on July 3, 2017 by Ben Brandt, Timo Horstschaefer, and Yoko Spirig in Zurich, Switzerland. | $10M | Series A | Sep 07, 2021 |  |
| Humanoo | HUMANOO \| MAKING PEOPLE HEALTHIER! HUMANOO is the digital health platform for employees and insurance clients. We enable our users to improve their physical and mental health. Simple, effective, proven - all in one app. With customized programs and innovative eHealth solutions, we guide our users in the areas of fitness, physio, yoga, mindfulnessand nutrition to their self-imposed goals. For the first time, companies and insurance companies can use comprehensive decentralized analysis to understand the health of their employees or insurance clients and make it a measurable success. Our team currently consists of 65 employees from 15 nations with different talents. In our office in Berlin-Kreuzberg, software developers, designers, marketing and sales specialists work together with sports and nutrition scientists as well as yoga teachers and physiotherapists. What we share is the goal to motivate people to stay healthy. | $10M | Series B | Aug 13, 2021 |  |
| Wunderflats | Wunderflats is an online platform that enables users to find and rent furnished apartments in Germany. It brings together tenants, landlords, and companies on one platform and makes renting a furnished apartment as convenient as possible. It was founded in 2014 and is headquartered in Berlin. | $21M | Series C | Jul 19, 2021 |  |
| Lengoo | Lengoo unlocks the potential of language data in enterprises. Our full-stack technology HALOS enables enterprises to build and operate custom language models at scale while adhering with state-of-the-art IT security and IP protection standards.For 5+ years, Lengoo has been supporting global industry leaders, hidden champions and scale-ups aroundthe globe in adopting AI securely. With our language intelligence Apps such as Flow and a powerful API, we empower every office worker with a trusted virtual AI partner making organization more efficient and therewith enabling continued growth. | $30M | Series B | Feb 09, 2021 |  |
| Humanoo | HUMANOO \| MAKING PEOPLE HEALTHIER! HUMANOO is the digital health platform for employees and insurance clients. We enable our users to improve their physical and mental health. Simple, effective, proven - all in one app. With customized programs and innovative eHealth solutions, we guide our users in the areas of fitness, physio, yoga, mindfulnessand nutrition to their self-imposed goals. For the first time, companies and insurance companies can use comprehensive decentralized analysis to understand the health of their employees or insurance clients and make it a measurable success. Our team currently consists of 65 employees from 15 nations with different talents. In our office in Berlin-Kreuzberg, software developers, designers, marketing and sales specialists work together with sports and nutrition scientists as well as yoga teachers and physiotherapists. What we share is the goal to motivate people to stay healthy. | $2.7M | Series A | Sep 07, 2020 |  |
| Tacalyx | Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms. | $7.4M | Seed | Sep 25, 2019 |  |
| Lengoo | Lengoo unlocks the potential of language data in enterprises. Our full-stack technology HALOS enables enterprises to build and operate custom language models at scale while adhering with state-of-the-art IT security and IP protection standards.For 5+ years, Lengoo has been supporting global industry leaders, hidden champions and scale-ups aroundthe globe in adopting AI securely. With our language intelligence Apps such as Flow and a powerful API, we empower every office worker with a trusted virtual AI partner making organization more efficient and therewith enabling continued growth. | $6.4M | Series A | Sep 02, 2019 |  |
| Wunderflats | Wunderflats is an online platform that enables users to find and rent furnished apartments in Germany. It brings together tenants, landlords, and companies on one platform and makes renting a furnished apartment as convenient as possible. It was founded in 2014 and is headquartered in Berlin. | $8.5M | Series B | Jul 08, 2019 |  |

10 of 93 investments shown.

## Co-investors
- [KfW](https://shizune.co/investors/profile/kfw) — VC Fund, 9 deals together
- [NRW.BANK](https://shizune.co/investors/profile/nrw-bank) — VC Fund, 6 deals together
- [XAnge](https://shizune.co/investors/profile/xange-private-equity) — VC Fund, 5 deals together
- [b2venture](https://shizune.co/investors/profile/btovpartners) — VC Fund, 4 deals together
- [Capnamic](https://shizune.co/investors/profile/capnamic-ventures) — VC Fund, 4 deals together
- [Heartcore Capital](https://shizune.co/investors/profile/heartcore-capital) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [All Investors in Germany](https://shizune.co/investors/investors-germany)
- [All VC Funds in Germany](https://shizune.co/investors/vc-funds-germany)
- [SaaS Investors in Germany](https://shizune.co/investors/saas-investors-germany)
- [SaaS VC Funds in Germany](https://shizune.co/investors/saas-vc-funds-germany)
- [Enterprise VC Funds in Germany](https://shizune.co/investors/enterprise-vc-funds-germany)
- [All VC Funds in Switzerland](https://shizune.co/investors/vc-funds-switzerland)

## FAQ

### What does Creathor Ventures invest in?

Creathor Ventures invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Funding Round stage. Most of the 93 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Creathor Ventures's check size?

Creathor Ventures typically joins rounds of $2M–$12M at Series A and $5.1M–$30M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Creathor Ventures participates in.

### How do I contact Creathor Ventures?

Public channels for Creathor Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Creathor Ventures?

The team at Creathor Ventures includes Angela Will-Jamin (PR & Team Assistant), Cedric Kohler (Managing Partner) and Gert Kohler (Founder and Chairman), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co